Report

  • Home |
  • Reports |
  • Global Gene Therapy Market by Type (Lentivirus, Adeno-associated viruses (AAV), ....
src

Global Gene Therapy Market by Type (Lentivirus, Adeno-associated viruses (AAV), Retrovirus & Gammaretroviral, Modified Herpes Simplex Virus, Adenovirus & Non-viral Plasmid Vector) and by End-Users/Application (Acute Lymphoblastic Leukemia (ALL), Inherited Retinal Disease, Large B-cell Lymphoma, ADA-SCID, Melanoma (Lesions), Beta-Thalassemia Major/SCD, Head & Neck Squamous Cell Carcinoma, Peripheral Arterial Disease, Spinal Muscular Atrophy (SMA) & Others) Global Market Share, Forecast Data, In-Depth Analysis, and Detailed Overview, and Forecast, 2015 - 2027

The report on the global gene therapy market analyzes complete scenario i.e., existing as well as future visions of gene therapy market. It includes detailed overview of gene therapy market along with market pictures. Additionally, report has included complete data of the various segments in the global gene therapy market followed by its applications, end users and region wide segmentation. Moreover, report has highlights of global key players present in this market. Top global players are analyzed completely along with their financials, technological innovations, key developments, apart from future strategies, SWOT analysis, acquisitions & mergers, and market footprint.

Global gene therapy market report offers in-depth insights, revenue details, and other vital information regarding the global gene therapy market, and the various trends, drivers, restraints, opportunities, and threats in the target market till year 2027. Hence, it covers the impact of these drivers and restraints on demand for this market during the forecast period. The report also includes PEST analysis, Porter’s Five Forces analysis, and opportunity map analysis for in-depth understanding of the market.

It provides historical data along with future forecast as well as detailed analysis of market on a global, regional and country level. Important market data of this market is projected in the form of form of tables, graphics, and pictures. On a regional basis, the market is categorized into five regions that include North America, Europe, Asia Pacific, Latin America, and Middle & East Africa. It analyzes complete scenario of each and every region along with highest share holder of gene therapy market.

Market Segmentation:
Segmentation by Type Lentivirus
Adeno-associated viruses
Retrovirus & Gammaretroviral
Modified Herpes Simplex Virus
Adenovirus
Non-viral Plasmid Vector
Segmentation by Application Acute Lymphoblastic Leukemia (ALL)
Inherited Retinal Disease
Large B-cell Lymphoma
ADA-SCID
Melanoma (Lesions)
Beta-Thalassemia Major/SCD
Head & Neck Squamous Cell Carcinoma
Peripheral Arterial Disease
Spinal Muscular Atrophy (SMA) 
Others
Market, By Regions North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, and Russia, etc.)
Asia-Pacific (China, Japan, ASEAN, India, and Korea)
The Middle East and Africa (UAE, Egypt, South Africa, Saudi Arabia)
South America (Brazil, Chile, Peru, and Argentina)

In addition, gene therapy market report sorted and categorized the information and data according to the major geographical regions which are expected to impact on the industry in forecast period.

Report also provides factors that are contributing to and influencing the expansion of the global gene therapy market. It projects the market assessment for the predicted time. Along with all these report includes the manufacturing process along with shipment, price, revenue, gross profit, potential, interview records, business distribution, etc. This enables users to get complete scenario of competitive analysis of the market.

Pivotal Fundamentals of the Global Gene therapy Market Report:
  • Holistic in-depth detailed analysis, regarding the parent market.
  • Detailed information about the current R&D activities performed by each gene therapy market player.
  • Region-wise and country-wise breakdown of the gene therapy market to get the revenue, and growth lookout in these areas.
  • Key factors which are influencing the consumption pattern of consumers across various regions and countries.
  • Historical and future progress of the global gene therapy market.
  • Year-on-year growth of the global gene therapy market in terms of value and volume.
Conclusion:
At last report covers a short outline of the dealers, distributors, and suppliers. Additionally, it provides sales channel, analysis findings and results. It spots some new entrants within the market. The study thus, suggests a brand new proposition to embellish gene therapy market and nurture business as it explains current global market as well as future market.
Chapter 1 Gene Therapy Market Overview
1.1 Product Overview and Scope of Gene Therapy

Chapter 2 Executive Summary  
2.1 Drivers for Gene Therapy Market: 
2.2 Restrain for Gene Therapy Market:
2.3 Opportunity for Gene Therapy Market: 
2.4 Global Gene Therapy market, 2015 - 2027
2.5 Global Gene Therapy market, by Region, 2015 - 2027
2.6 Global Gene Therapy market, by Type, 2015 - 2027
2.7 Global Gene Therapy market, by Application, 2015 - 2027

Chapter 3 Gene Therapy Segment by Vector Types (Product Category) 
3.1 Global Gene Therapy Revenue (USD Million) and Growth Rate (%) Comparison by Types  (2015-2020) 
3.2 Global Gene Therapy Revenue Market Share (%) by Types in 2019
3.3 Lentivirus
3.4 Adeno-associated viruses
3.5 Retrovirus & Gammaretroviral
3.6 Modified Herpes Simplex Virus
3.7 Adenovirus
3.8 Non-viral Plasmid Vector 

Chapter 4 Global Gene Therapy Segment by Application 
4.1 Global Gene Therapy Revenue (USD Million) Comparison by Application (2015-2027) 
4.2 Acute Lymphoblastic Leukemia (ALL)
4.3 Inherited Retinal Disease
4.4 Large B-cell Lymphoma
4.5 ADA-SCID
4.6 Melanoma (Lesions)
4.7 Beta-Thalassemia Major/SCD
4.8 Head & Neck Squamous Cell Carcinoma
4.9 Peripheral Arterial Disease
4.10 Spinal Muscular Atrophy (SMA) 
4.11 Others

Chapter 5 Global Gene Therapy Market by Regions (2015-2027) 
5.1 Global Gene Therapy Market Size and Growth Rate (%) Comparison by Regions (2015-2027) 
5.2 North America Gene Therapy Status and Prospect (2015-2027) 
5.3 Europe Gene Therapy Status and Prospect (2015-2027) 2
5.4 Asia Pacific Gene Therapy Status and Prospect (2015-2027) 3
5.5 South America Gene Therapy Status and Prospect (2015-2027) 
5.6 Middle East & Africa Gene Therapy Status and Prospect (2015-2027) 
5.7 Global Gene Therapy Market Size (2015-2027) 
            5.7.1 Global Gene Therapy Revenue Status and Outlook (2015-2027) 
            
Chapter 6 Global Gene Therapy Market Competition by Manufacturers
6.1 Global Gene Therapy Revenue and Share by Manufacturers (2015-2019) 

Chapter 7 Company (Top Players) Profiles and Key Data
7.1 Novartis AG
            7.1.1 Company Basic Information and Sales Area
            7.1.2 Business Segment/ Overview
            7.1.3 Investment in Research and Development
            7.1.4 Gene Therapy Product Types Specification
            7.1.5 Key Developments
            7.1.6 Business Strategy
7.2 Spark Therapeutics LLC 
            7.2.1 Company Basic Information and Sales Area
            7.2.2 Business Segment/ Overview
            7.2.3 Investment in Research and Development
            7.2.4 Gene Therapy Product Types Specification
            7.2.5 Business Strategy
7.3 Bluebird Bio  
            7.3.1 Company Basic Information, and Sales Area
            7.3.2 Business Segment/ Overview
            7.3.3 Gene Therapy Product Types Specification
            7.3.4 Key Developments
            7.3.5 Business Strategy
7.4 Gilead Sciences Inc. 
            7.4.1 Company Basic Information and Sales Area. 
            7.4.2 Business Segment/ Overview
            7.4.3 Gene Therapy Product Types Specification
            7.4.4 Business Strategy
7.5 Celgene Corporation 
            7.5.1 Company Basic Information and Sales Area. 
            7.5.2 Business Segment/ Overview
            7.5.3 Gene Therapy Product Types Specification
            7.5.4 Business Strategy
7.6 GlaxoSmithKline 
            7.6.1 Company Basic Information, and Sales Area
            7.6.2 Business Segment/ Overview
            7.6.3 Gene Therapy Product Types Specification
            7.6.4 Business Strategy
7.7 Sangamo Biosciences 
            7.7.1 Company Basic Information, and Sales Area
            7.7.2 Business Segment/ Overview
            7.7.3 Investment in Research and Development
            7.7.4 Gene Therapy Product Types Specification
            7.7.5 Key Developments
            7.7.6 Business Strategy
7.8 Shire Plc 
            7.8.1 Company Basic Information and Sales Area. 
            7.8.2 Business Segment/ Overview
            7.8.3 Gene Therapy Product Types Specification
            7.8.4 Business Strategy
7.9 Voyager Therapeutics 
            7.9.1 Company Basic Information, and Sales Area
            7.9.2 Business Segment/ Overview
            7.9.3 Gene Therapy Product Types Specification
            7.9.4 Business Strategy
7.10 Dimension Therapeutics
            7.10.1 Company Basic Information, and Sales Area
            7.10.2 Business Segment/ Overview
            7.10.3 Gene Therapy Product Types Specification
            7.10.4 Business Strategy
            
Chapter 8 Global Gene Therapy Revenue by Regions (2015-2020) 
8.1 Global Gene Therapy Revenue and Market Share (%) by Regions (2015-2020) 

Chapter 9 Global Gene Therapy Revenue by Types
9.1 Global Gene Therapy Revenue and Market Share (%) by Types (2015-2020) 

Chapter 10 Global Gene Therapy Market Analysis by Application
10.1 Global Gene Therapy Revenue (USD Million) and Market Share (%) by Application (2015-2020) 
10.2 Global Gene Therapy Revenue Growth Rate by Application (2015-2020) 

Chapter 11 North America Gene Therapy Market Development Status and Outlook
11.1 North America Gene Therapy Market Size (2015-2020) 
            11.1.1 North America Gene Therapy Market Size by Type (USD Million) (2015-2020) 
11.2 North America Gene Therapy Market Size (2015-2020) 
            11.2.1 North America Gene Therapy Market Size by Application (USD Million) (2015-2020) 
11.3 U.S
            11.3.1 U.S. Gene Therapy market, by Type, 2015 - 2027
            11.3.2 U.S. Gene Therapy market, by Application, 2015 – 2027
11.4 Canada
            11.4.1 Canada Gene Therapy market, by Type, 2015 - 2027
            11.4.2 Canada Gene Therapy market, by Application, 2015 – 2027
11.5 Mexico
            11.5.1 Mexico Gene Therapy market, by Type, 2015 - 2027
            11.5.2 Mexico Gene Therapy market, by Application, 2015 – 2027
            
Chapter 12 Europe Gene Therapy Market Development Status and Outlook
12.1 Europe Gene Therapy Market Size (2015-2020) 
            12.1.1 Europe Gene Therapy Market Size by Type (USD Million) (2015-2020) 
12.2 Europe Gene Therapy Market Size (2015-2020) 
            12.2.1 Europe Gene Therapy Market Size by Application (USD Million) (2015-2020) 
12.3 U.K.
            12.3.1 U.K. Gene Therapy market, by Type, 2015 - 2027
            12.3.2 U.K. Gene Therapy market, by Application, 2015 – 2027
12.4 Germany
            12.4.1 Germany Gene Therapy market, by Type, 2015 - 2027
            12.4.2 Germany Gene Therapy market, by Application, 2015 – 2027
12.5 France
            12.5.1 France Gene Therapy market, by Type, 2015 – 2027
            12.5.2 France Gene Therapy market, by Application, 2015 – 2027
12.6 Italy
            12.6.1 Italy Gene Therapy market, by Type, 2015 – 2027
            12.6.2 Italy Gene Therapy market, by Application, 2015 – 2027
12.7 Spain
            12.7.1 Spain Gene Therapy market, by Type, 2015 – 2027
            12.7.2 Spain Gene Therapy market, by Application, 2015 – 2027
12.8 Rest of Europe
            12.8.1 Rest of Europe Gene Therapy market, by Type, 2015 – 2027
            12.8.2 Rest of Europe Gene Therapy market, by Application, 2015 – 2027
            
Chapter 13 Asia Pacific Gene Therapy Market Development Status and Outlook
13.1 Asia Pacific Gene Therapy Market Size (2015-2020) 
            13.1.1 Asia Pacific Gene Therapy Market Size by Type (USD Million) (2015-2020) 
13.2 Asia Pacific Gene Therapy Market Size (2015-2020) 
            13.2.1 Asia Pacific Gene Therapy Market Size by Application (USD Million) (2015-2020) 
13.3 China
            13.3.1 China Gene Therapy market, by Type, 2015 – 2027
            13.3.2 China Gene Therapy market, by Application, 2015 – 2027
13.4 Japan
            13.4.1 Japan Gene Therapy market, by Type, 2015 – 2027
            13.4.2 Japan Gene Therapy market, by Application, 2015 – 2027
13.5 India
            13.5.1 India Gene Therapy market, by Type, 2015 – 2027
            13.5.2 India Gene Therapy market, by Application, 2015 – 2027
13.6 Southeast Asia
            13.6.1 Southeast Asia Gene Therapy market, by Type, 2015 – 2027
            13.6.2 Southeast Asia Gene Therapy market, by Application, 2015 – 2027
            
Chapter 14 South America Gene Therapy Market Development Status and Outlook
14.1 South America Gene Therapy Market Size (2015-2020) 
            14.1.1 South America Gene Therapy Market Size by Type (USD Million) (2015-2020) 
14.2 South America Gene Therapy Market Size (2015-2020) 
            14.2.1 South America Gene Therapy Market Size by Application (USD Million) (2015-2020) 
14.3 Brazil
            14.3.1 Brazil Gene Therapy market, by Type, 2015 – 2027
            14.3.2 Brazil Gene Therapy market, by Application, 2015 – 2027 
14.4 Argentina
            14.4.1 Argentina Gene Therapy market, by Type, 2015 – 2027
            14.4.2 Argentina Gene Therapy market, by Application, 2015 – 2027 
14.5 Colombia
            14.5.1 Colombia Gene Therapy market, by Type, 2015 – 2027
            14.5.2 Colombia Gene Therapy market, by Application, 2015 – 2027
14.6 Rest of South America
            14.6.1 Colombia Gene Therapy market, by Type, 2015 – 2027
            14.6.2 Colombia Gene Therapy market, by Application, 2015 – 2027
            
Chapter 15 Middle East & Africa Gene Therapy Market Development Status and Outlook
15.1 Middle East & Africa Gene Therapy Market Size (2015-2020) 
            15.1.1 Middle East & Africa Gene Therapy Market Size by Type (USD Million) (2015-2020) 
15.2 Middle East & Africa Gene Therapy Market Size (2015-2020) 
            15.2.1 Middle East & Africa Gene Therapy Market Size by Application (2015-2020) 
15.3 UAE
            15.3.1 UAE Gene Therapy market, by Type, 2015 – 2027
            15.3.2 UAE Gene Therapy market, by Application, 2015 – 2027
15.4 South Africa
            15.4.1 South Africa Gene Therapy market, by Type, 2015 – 2027
            15.4.2 South Africa Gene Therapy market, by Application, 2015 – 2027
15.5 Egypt
            15.5.1 Egypt Gene Therapy market, by Type, 2015 – 2027
            15.5.2 Egypt Gene Therapy market, by Application, 2015 – 2027
15.6 Rest of MEA
            15.6.1 Rest of MEA Gene Therapy market, by Type, 2015 – 2027
            15.6.2 Rest of MEA Gene Therapy market, by Application, 2015 – 2027
            
Chapter 16 Gene Therapy Manufacturing Cost Analysis
16.1 Proportion of Manufacturing Cost Structure
            16.1.1 Raw Materials
            16.1.2 Labor Cost
            16.1.3 USA Labor Cost Analysis
            16.1.4 EU Labor Costs Analysis
            16.1.5 China Labor Costs Analysis
            16.1.6 Manufacturing Expenses
            
Chapter 17 Marketing Strategy Analysis, Distributors/ Traders
17.1 Marketing Channel
            17.1.1 Direct Marketing
            17.1.2 Indirect Marketing
            17.1.3 Marketing Channel Development Trend
17.2 Market Positioning
            17.2.1 Pricing Strategy
            
Chapter 18 Global Gene Therapy Market Forecast (2020-2027) 
18.1 Global Gene Therapy Revenue Forecast (2020-2027) 
            18.1.1 Global Gene Therapy Revenue (USD Million) and Growth Rate (%) Forecast (2020-2027) 
18.2 Global Gene Therapy Revenue (USD Million) Forecast by Regions (2020-2027) 
            18.2.1 North America Gene Therapy Revenue (USD Million) Forecast (2020-2027) 
            18.2.2 Europe Gene Therapy Revenue (USD Million) Forecast (2020-2027) 
            18.2.3 Asia Pacific Gene Therapy and Revenue (USD Million) Forecast (2020-2027) 
            18.2.4 South America Gene Therapy and Revenue (USD Million) Forecast (2020-2027) 
            18.2.5 Middle East & Africa Gene Therapy and Revenue (USD Million) Forecast (2020-2027) 
18.3 Global Gene Therapy Revenue Forecast by Type (2020-2027) 
18.4 Global Gene Therapy Revenue (USD Million) Forecast by Application (2020-2027) 

Chapter 19 North America Gene Therapy Market Development Status and Outlook
19.1 North America Gene Therapy Market Size (2020-2027) 
            19.1.1 North America Gene Therapy Market Size by Type (USD Million) (2020-2027) 
19.2 North America Gene Therapy Market Size (2020-2027) 
            19.2.1 North America Gene Therapy Market Size by Application (USD Million) (2020-2027) 
19.3 U.S.
            19.3.1 U.S. Gene Therapy market, by Type, 2020 – 2027
            19.3.2 U.S. Gene Therapy market, by Application, 2020 – 2027
19.4 Canada
            19.4.1 Canada Gene Therapy market, by Type, 2020 – 2027
            19.4.2 Canada Gene Therapy market, by Application, 2020 – 2027
19.5 Mexico
            19.5.1 Mexico Gene Therapy market, by Type, 2020 – 2027
            19.5.2 Mexico Gene Therapy market, by Application, 2020 – 2027
            
Chapter 20 Europe Gene Therapy Market Development Status and Outlook
20.1 Europe Gene Therapy Market Size (2020-2027) 
            20.1.1 Europe Gene Therapy Market Size by Type (USD Million) (2020-2027) 
20.2 Europe Gene Therapy Market Size (2020-2027) 
            20.2.1 Europe Gene Therapy Market Size by Application (USD Million) (2020-2027) 
20.3 U.K.
            20.3.1 U.K. Gene Therapy market, by Type, 2020 – 2027
            20.3.2 U.K. Gene Therapy market, by Application, 2020 – 2027
20.4 Germany
            20.4.1 Germany Gene Therapy market, by Type, 2020 – 2027
            20.4.2 Germany Gene Therapy market, by Application, 2020 – 2027
20.5 France
            20.5.1 France Gene Therapy market, by Type, 2020 – 2027
            20.5.2 France Gene Therapy market, by Application, 2020 – 2027
20.6 Italy
            20.6.1 France Gene Therapy market, by Type, 2020 – 2027
            20.6.2 France Gene Therapy market, by Application, 2020 – 2027
20.7 Spain
            20.7.1 France Gene Therapy market, by Type, 2020 – 2027
            20.7.2 France Gene Therapy market, by Application, 2020 – 2027
20.8 Rest of Europe
            20.8.1 France Gene Therapy market, by Type, 2020 – 2027
            20.8.2 France Gene Therapy market, by Application, 2020 – 2027
            
Chapter 21 Asia Pacific Gene Therapy Market Development Status and Outlook
21.1 Asia Pacific Gene Therapy Market Size (2020-2027) 
            21.1.1 Asia Pacific Gene Therapy Market Size by Type (USD Million) (2020-2027) 
21.2 Asia Pacific Gene Therapy Market Size (2020-2027) 
            21.2.1 Asia Pacific Gene Therapy Market Size by Application (USD Million) (2020-2027) 
21.3 China
            21.3.1 China Gene Therapy market, by Type, 2020 – 2027
            21.3.2 China Gene Therapy market, by Application, 2020 – 2027
21.4 Japan
            21.4.1 Japan Gene Therapy market, by Type, 2020 – 2027
            21.4.2 Japan Gene Therapy market, by Application, 2020 – 2027
21.5 India
            21.5.1 India Gene Therapy market, by Type, 2020 – 2027
            21.5.2 India Gene Therapy market, by Application, 2020 – 2027
21.6 Southeast Asia
            21.6.1 Southeast Asia Gene Therapy market, by Type, 2020 – 2027
            21.6.2 Southeast Asia Gene Therapy market, by Application, 2020 – 2027
            
Chapter 22 South America Gene Therapy Market Development Status and Outlook
22.1 South America Gene Therapy Market Size (2020-2027) 
            22.1.1 South America Gene Therapy Market Size by Type (USD Million) (2020-2027) 
22.2 South America Gene Therapy Market Size (2020-2027) 
            22.2.1 South America Gene Therapy Market Size by Application (USD Million) (2020-2027) 
22.3 Brazil
            22.3.1 Brazil Gene Therapy market, by Type, 2020 – 2027
            22.3.2 Brazil Gene Therapy market, by Application, 2020 – 2027 
22.4 Argentina
            22.4.1 Argentina Gene Therapy market, by Type, 2020 – 2027
            22.4.2 Argentina Gene Therapy market, by Application, 2020 – 2027 
22.5 Colombia
            22.5.1 Colombia Gene Therapy market, by Type, 2020 – 2027
            22.5.2 Colombia Gene Therapy market, by Application, 2020 – 2027
22.6 Rest of South America
            22.6.1 Colombia Gene Therapy market, by Type, 2020 – 2027
            22.6.2 Colombia Gene Therapy market, by Application, 2020 – 2027
            
Chapter 23 Middle East & Africa Gene Therapy Market Development Status and Outlook
23.1 Middle East & Africa Gene Therapy Market Size (2020-2027) 
            23.1.1 Middle East & Africa Gene Therapy Market Size by Type (USD Million) (2020-2027) 
23.2 Middle East & Africa Gene Therapy Market Size (2020-2027) 
            23.2.1 Middle East & Africa Gene Therapy Market Size by Application (USD Million) (2020-2027) 
23.3 UAE
            23.3.1 UAE Gene Therapy market, by Type, 2020 – 2027
            23.3.2 UAE Gene Therapy market, by Application, 2020 – 2027
23.4 South Africa
            23.4.1 South Africa Gene Therapy market, by Type, 2020 – 2027
            23.4.2 South Africa Gene Therapy market, by Application, 2020 – 2027
23.5 Egypt
            23.5.1 Egypt Gene Therapy market, by Type, 2020 – 2027
            23.5.2 Egypt Gene Therapy market, by Application, 2020 – 2027
24.6 Rest of MEA
            24.6.1 Rest of MEA Gene Therapy market, by Type, 2020 – 2027
            24.6.2 Rest of MEA Gene Therapy market, by Application, 2020 – 2027
            
Chapter 25 Research Findings and Conclusion
 
No Methodology
Global Gene Therapy Market Trends:
The global gene therapy is estimated to be worth USD 1,200 million in 2019 and is projected to reach USD 6,600 million by 2027, at a CAGR of 16.6% from 2020 to 2027.

Gene therapy is the introduction of DNA into a patient to treat a genetic disease or a disorder. The newly inserted DNA contains a correcting gene to correct the effects of a disease, causing mutations. Gene therapy is a promising treatment for genetic diseases and also includes cystic fibrosis and muscular dystrophy. Gene therapy is a suitable treatment for infectious diseases, inherited disease and cancer. The growth of the gene therapy market is regulated due to various reason which includes the rapid involvement of synthetically modified gene to treat various diseases, it helps in designing the personalized medicine, rise in the research and development of the gene therapy among the others.

Increasing incidence of cancer and rare life threatening diseases and strong clinical pipeline drugs for gene therapy are major drivers for market growth. Additionally, improving regulatory scenario will boost the cancer gene therapy industry growth during analysis timeframe. However, High cost of cancer gene therapy may create affordability issues thereby, restraining the cancer gene therapy market growth.

Global Gene Therapy Market, By Type:
Based on type, the market is categorized into Lentivirus, Adeno-associated viruses (AAV), Retrovirus & Gammaretroviral, Modified Herpes Simplex Virus, Adenovirus & Non-viral Plasmid Vector. On the basis of type, Lentivirus accounted for largest share of total revenue generated. Because, key developers are increasingly interested in this vector type, post-approval of Zynteglo in 2019 and Kymriah in 2017. Furthermore, the presence of companies that offer an exclusive Lentivector platform to key gene therapy developers is driving the segment growth. Several biopharmaceutical companies such as Novartis, Orchard Therapeutics, Sanofi, GSK, and ImmuneDesign have collaborated with Oxford Biomedica to use its Lentivector platform, which is boosting the segmental growth.
 
Global Gene Therapy, By Application:
Based on indication, the market is categorized into Acute Lymphoblastic Leukemia (ALL), Inherited Retinal Disease, Large B-cell Lymphoma, ADA-SCID, Melanoma (Lesions), Beta-Thalassemia Major/SCD, Head & Neck Squamous Cell Carcinoma, Peripheral Arterial Disease, Spinal Muscular Atrophy (SMA) & others. The demand of Global Gene therapy Market is highest from Acute Lymphoblastic Leukaemia due to an increase in the number of molecules being tested across various clinical trials, the trials intended for the development of cancer therapies are leading the count. For instance, Novartis is focusing on extending its approval of Kymriah, a gene therapy designed for the treatment of haematological cancer, in other established and emerging countries. This is anticipated to drive the acute lymphoblastic leukaemia (ALL).

Global Gene Therapy market, By Region:
Report covers the region wise analysis, global gene therapy market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Among all, Europe leads the global gene therapy market share followed by North America & Asia Pacific. While the Europe leads the global gene therapy market due to the  large number of aging population and technological advancement in the region. Moreover, the increasing government initiatives, rising economy and improvement in healthcare infrastructure in this region are boosting the growth of the market. Some of the key driving forces for gene therapy market are increasing R&D investment, large pool of patients and rising government funding are the factors fueling the growth of the market.

Major Market Players:
The research study includes profiles of leading companies operating in the global gene therapy market. Key players profiled in the report include: Novartis AG, Spark Therapeutics LLC, Bluebird Bio, Gilead Sciences Inc., Celgene Corporation, GlaxoSmithKline, Sangamo Biosciences, Shire Plc, Voyager Therapeutics & Dimension Therapeutics.

Global Gene Therapy Market Report Scope:
Report Parameters Details of Parameter
Market Size 2015-2027
Based Year 2019
Forecast Period Covered 2020-2027
Units for value USD (Million)
Covered Segments Product Type, Applications, Geographic Regions
Product Type Lentivirus, Adeno-associated viruses (AAV), Retrovirus & Gammaretroviral, Modified Herpes Simplex Virus, Adenovirus & Non-viral Plasmid Vector
Applications Acute Lymphoblastic Leukemia (ALL), Inherited Retinal Disease, Large B-cell Lymphoma, ADA-SCID, Melanoma (Lesions), Beta-Thalassemia Major/SCD, Head & Neck Squamous Cell Carcinoma, Peripheral Arterial Disease, Spinal Muscular Atrophy (SMA) & Others
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Covered Novartis AG, Spark Therapeutics LLC, Bluebird Bio, Gilead Sciences Inc., Celgene Corporation, GlaxoSmithKline, Sangamo Biosciences, Shire Plc, Voyager Therapeutics & Dimension Therapeutics

The report analyzes all the factors which are impacting on the market and on that basis describes the drivers, restraints, and opportunities for the growth of the global gene therapy market. Similarly, report provides the all the segmentations along with the qualitative analysis.

Global Gene Therapy Market:  Product analysis
  • Lentivirus
  • Adeno-associated viruses
  • Retrovirus & Gammaretroviral
  • Modified Herpes Simplex Virus
  • Adenovirus
  • Non-viral Plasmid Vector
Global Gene Therapy Market: Application analysis
  • Acute Lymphoblastic Leukemia (ALL)
  • Inherited Retinal Disease
  • Large B-cell Lymphoma
  • ADA-SCID
  • Melanoma (Lesions)
  • Beta-Thalassemia Major/SCD
  • Head & Neck Squamous Cell Carcinoma
  • Peripheral Arterial Disease
  • Spinal Muscular Atrophy (SMA)
  • Others
Market, by regions:
In addition, gene therapy report sorted and categorized the information and data according to the major geographical regions which are expected to impact on the industry in forecast period. Following are the regions we covered in this report:
  • North America (U.S., Canada, Mexico)
  • Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)
  • Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)
  • Latin America (Brazil, Rest of L.A.)
  • Middle East and Africa (Turkey, GCC, Rest of Middle East)